🌍·17h agoIndustry
UCB Annual General Meeting of Shareholders 2026
UCB Annual General Meeting of Shareholders 2026 | UCB
Publisher
U
UCB
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Summary excerpt
UCB Annual General Meeting of Shareholders 2026 | UCB
Source route
Continue on ucb.com
Leave the platform to read the original full article on the publisher site.
Source: UCB
Scope: Industry
Related coverage
More related coverage
UCB·1d ago
UCB receives positive CHMP opinion for new ZILBRYSQ[®]▼ (zilucoplan) pre-filled pen in EU for adults...
ZILBRYSQ® (zilucoplan) pre-filled pen offers the same complement component 5 (C5) inhibitor as the p...
GSK RSS·5h ago
27 March 2026Bepirovirsen accepted for review by the European Medicines Agency as a potential first-in-class treatment for chronic hepatitis BSubmission supported by statistically significant and clinically meaningful functional cure rates in pivotal PhIII B-Well trials
Pharmaceutical Technology·5h ago
Rocket’s gene therapy Kresladi wins FDA approval in rare immune disease
Pharmaceutical Technology·5h ago